Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

US Patent 10028944 · Granted Jul 24, 2018

Estimated economic value: $29,067,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods2025
Methods of treating acute depression2025
Compounds2025
Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-he2025
Organic compounds2025
Organic compounds2025
Methods of treating inflammatory disease2025
Transmucosal methods for treating psychiatric and neurological conditions2025
Organic compounds2025
Transmucosal methods for treating psychiatric and neurological conditions2025
Organic compounds2025
Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-h2025